Call me a fool, but there is something about this company that I like. They have been working hard to reduce costs and open new markets. They are already an international company, and have begun the final phase of clinical trials in the US for the Robodoc system, a great product. Not to mention the fact that they have finally turned a profit. They have had positive earnings for the last two quarters, the first profit since their IPO. Tough times are still ahead, but they have shown that they have what it takes to fight through.
When I first began investing in RDOC I was playing with a few biotechs. I was making money, but did not like financing irresponsible science. I began looking for a small medical company that was innovative but still used tried and true scientific methods and technology. RDOC seemed to fit the bill, but had one small problem. Their Robodoc system was not approved in the US yet. I watched as the price dropped below a dollar and kept falling. I understood why, but that did not make it any easier to watch. It makes you wonder how so many harmful drugs get approved so quickly while a truly beneficial system like Robodoc is sitting in trials while the company fights for its life.
My father could have benefited greatly if Robodoc were available in the US. He has had 3 hip replacement surgeries, one of which almost killed him due to infection caused by poor fit. I can't even begin to tell you how much pain he has gone through. One leg is now longer than the other and he has to wear a special shoe to walk properly. When I read about the Robodoc procedure, I vowed to put as much money into this company as I could afford to lose.
To be completely forthcoming, I now own over 580,000 shares, which at 3 cents per share is currently only worth $15 thousand. I bought a bit around 8 cents and the rest at 3 cents.
The possibility of returns in this company are huge, if it reaches a dollar, my shares will be worth $580,000.00. If it goes under they'll be worth zero, but my gut tells me it won't. I have had total losses and large gainers in the past. This stock feels more like a winner.
I noticed that the volume shot up over a million shares with a rise in price a few days ago. Looks like someone is buying.
My strategy is to buy at 0.03 and hold. I will probably play the short term rises and drops with about 30 percent of my holding, and hold the rest for the long term.
I would like to hear others opinions about the future of the company, clinical trials, and investing strategies for RDOC.
AI
